Substandard Neostigmine: A Cause of Post - Operative Non - Cardiogenic Pulmonary Oedema

Abstract

during the month of December 2007 after reversal of neuromuscular block with Neostigmine resulting in morbidity. The drug was newly supplied on a rate contract basis to Government hospitals. The incidence was reported to the authorities. Further use of the drug stopped and the sample sent to Food and Drugs Administration department (FDA) for analysis. FDA analyzed the drug and reported that it was of a "Substandard Quality". We are presenting 2 cases of Non-cardiogenic pulmonary edema occurred after the use of this "Substandard Neostigmine".